Flare
FLR#253$0.01
-0.42% (24H)
Market Cap
$101.72M
+0.28%
24H Volume
$1472
Circ. Supply
-
Total Supply
100.56B FLR
Max Supply
∞
FDV
-
Dominance
-
All-Time High
-
Flare (FLR) News
The latest Flare (FLR) news in one feed: protocol upgrades, partnership announcements, regulatory updates and price analysis, curated by BTI.
AbbVie's Lutikizumab Clears Phase 3, but the Benefit Is Modest
Lutikizumab met its Phase 3 hidradenitis suppurativa goal, with 31.4% of patients reaching HiSCR75 versus 23.4% on placebo. Pain, flare and safety results support a filing, but the absolute response gap tempers commercial expectations.
NuScale’s $75,000 Quarter Makes Contract Timing the Central Risk
NuScale’s quarterly revenue nearly disappeared after Romanian engineering work ended. A large cash balance provides time, but only a binding customer contract can rebuild recurring revenue.
Market data is provided for informational purposes only. Not investment advice. Past performance is not indicative of future results.